TP53BP1 and cancer: To perform this work, we have developed a semi-automated, high-throughput method to quantify DNA damage and repair based on 53BP1 immunocytochemistry of PBMC subtypes and applied it to immune cells isolated from healthy donors and cancer patients using a venous blood draw or a finger prick.